IMHA: Diagnosing and treating a complex disease - Veterinary Medicine
  • SEARCH:
Medicine Center
DVM Veterinary Medicine Featuring Information from:

ADVERTISEMENT

IMHA: Diagnosing and treating a complex disease
Differentiating IMHA from other causes of hemolytic anemia is challenging, but a careful diagnostic process will help you determine whether your veterinary patients will require long-term immunosuppressive therapy.


VETERINARY MEDICINE


18. Boozer L, Macintire D. Babesia gibsoni: An emerging pathogen in dogs. Compend Contin Educ Pract Vet 2005;27(1):33-41.

19. Macintire DK, Boudreaux MK, West GD, et al. Babesia gibsoni infection among dogs in the southeastern United States. J Am Vet Med Assoc 2002;220(3):325-329.

20. Stegeman JR, Birkenheuer AJ, Kruger JM, et al. Transfusion-associated Babesia gibsoni infection in a dog. J Am Vet Med Assoc 2003;222(7):959-963.

21. Birkenheuer AJ, Correa MT, Levy MG, et al. Geographic distribution of babesiosis among dogs in the United States and association with dog bites: 150 cases (2000-2003). J Am Vet Med Assoc 2005;227(6):942-947.

22. Neer MN. Ehrlichiosis. In: Greene CE, ed. Infectious diseases of the dog and cat. 2nd ed. Philadelphia, Pa: WB Saunders, 1998;139-147.

23. Strickland KN. Canine and feline caval syndrome. Clin Tech Small Anim Pract 1998;13(2):88-95.

24. McCullough S. Immune-mediated hemolytic anemia: understanding the nemesis. Vet Clin North Am Small Anim Pract 2003;33(6):1295-1315.

25. Scott-Moncrieff JC, Treadwell NG, McCullough SM, et al. Hemostatic abnormalities with primary immune-mediated hemolytic anemia. J Am Anim Hosp Assoc 2001;37(3):220-227.

26. Day MJ. Systemic lupus erythematosus. In: Feldman BF, Zinkl JG, Jain NC, eds. Schalm's veterinary hematology. 5th ed. Philadelphia, Pa: Lippincott, Williams & Wilkins, 2000;819-826.

27. Scott-Moncrieff JC. Immune-mediated hemolytic anemia: Treatment. In: IMHA: New perspectives on a challenging disease. Thomson Veterinary Healthcare Communications, Lenexa, Kan, 2002:7-11. In: Vet Med 97(10). Sponsored insert.

28. Reimer ME, Troy GC, Warnick LD. Immune-mediated hemolytic anemia: 70 cases (1988-1996). J Am Anim Hosp Assoc 1999;35(5):384-391.

29. Grundy SA, Barton C. Influence of drug treatment on survival of dogs with immune-mediated hemolytic anemia: 88 cases (1989-1999). J Am Vet Med Assoc 2001;218(4):543-546.

30. Mason N, Duval D, Shofer FS, et al. Cyclophosphamide exerts no beneficial effect over prednisone alone in the initial treatment of acute immune-mediated hemolytic anemia in dogs: a randomized controlled clinical trial. J Vet Intern Med 2003;17(2):206-212.

31. Gregory CR. Immunosuppressive agents. In: Kirk's current veterinary therapy XIII small animal practice. Philadelphia, Pa: WB Saunders Co, 2000;509-513.

32. Nielsen L, Niessen S, Ramsay IK, et al. The use of mycophenolate mofetil in eight dogs with idiopathic immune mediated haemolytic anaemia, in Proceedings. European Coll Vet Intern Med Companion Anim Congress 2005.

33. Miller E. The use of danazol in the therapy of immune-mediated disease of dogs. Semin Vet Med Surg (Small Anim) 1997;12(3):167-169.

34. White HL, O'Toole TE, Rozanski EA, et al. Early treatment of canine immune-mediated hemolytic anemia with intravenous immunoglobulin: 11 cases (1998-2001) (abst). J Vet Intern Med 2002;16(3):318.

35. Mathes M, Jordan M, Dow S. Evaluation of liposomal clodronate in experimental spontaneous autoimmune hemolytic anemia in dogs. Exp Hematol 2006;34(10):1393-1402.

36. Lunn KF. Liposomal clodronate as a novel treatment for immune-mediated hemolytic anemia in dogs. Clinical Trials and Research Projects, Colorado State University, Fort Collins, CO. Personal communication, October 2008.

37. Toll, J, Aronsohn M. Prospective evaluation of medical therapy with or without early splenectomy for treatment of severe immune-mediated hemolytic anemia in the dog, in Proceedings, Am Coll Vet Intern Med 2003.

38. Thompson MF, Scott-Moncreiff JC, Brooks MB. Effect of a single plasma transfusion on thromboembolism in 13 dogs with primary immune-mediated hemolytic anemia. J Am Anim Hosp Assoc 2004;40(6):446-454.

39. Breuhl EL, Scott-Moncrieff C, Brooks M. A prospective study of unfractionated heparin therapy to prevent thrombosis in canine immune-mediated hemolytic anemia, in Proceedings. Am Coll Vet Intern Med 2005.

40. Birkenheuer AJ, Le JA, Valenzisi AM, et al. Cytauxzoon felis infection in cats in the mid-Atlantic states: 34 cases (1998-2004). J Am Vet Med Assoc 2006;228(4):568-571.

41. Kohn B, Weingart C, Eckmann V, et al. Primary immune-mediated hemolytic anemia in 19 cats: diagnosis, therapy, and outcome (1998-2004). J Vet Intern Med 2006;20(1):159-166.

42. de Brito Galvao JF, Trepanier LA. Risk of hemolytic anemia with intravenous administration of famotidine to hospitalized cats. J Vet Intern Med 2008;22(2):325-329.

43. Noble SJ, Armstrong PJ. Bee sting envenomation in secondary immune-mediated hemolytic anemia in two dogs. J Am Vet Med Assoc 1999;214(7):1026-1027.

44. Trepanier L. Idiosyncratic toxicity associated with potentiated sulfonamides in the dog. J Vet Pharmacol Ther 2004:27(3):129-138.

45. Bloom JC, Thiem PA, Sellers TS, et al. Cephalosporin-induced immune mediated cytopenia in the dog: demonstration of erythrocyte-, neutrophil-, and platelet- associated IgG following treatment with cefazedone. Am J Hematol 1988:28(2):71-78.

46. Peterson M. Hyperthyroidism. In: Ettinger SJ, Feldman EC, eds. Textbook of veterinary internal medicine. 5th ed. St. Louis, Mo: Elsevier Co, 2000;1410-1411.

47. EC Feldman, RW Nelson. Feline hyperthyroidism (thyrotoxicosis). Canine and feline endocrinology and reproduction. 3rd ed. St. Louis, Mo: Elsevier Co, 2004;152-218.

48. Bexfield NH, Villiers EJ, Herrtage ME. Immune-mediated haemolytic anemia and thrombocytopenia associated with Anaplasma phagocytophilum in a dog. J Small Anim Pract 2005;46(11):543-548.


ADVERTISEMENT

Source: VETERINARY MEDICINE,
Click here